Recent findings suggest that haploinsufficiency for the two tumor suppressor genes PTCH (patched (Drosophila) homolog (nevoid basal cell carcinoma syndrome)) and SUFU (suppressor of fused homolog)-which are both active in this signaling pathway-is frequent in ERMS development [22]. This evidence concerns the gene SUFU and nevoid basal cell carcinoma syndrome.